MedPath

Clinical Trial on the Effectiveness of Herbal Medicinal Mixture in Parkinson Disease

Phase 2
Completed
Conditions
Parkinson's Disease
Interventions
Drug: Placebo
Drug: Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.)
Registration Number
NCT00656253
Lead Sponsor
Fudan University
Brief Summary

This study was designed to evaluate the symptomatic effects or potential disease progression slowing down effect of a kind of Herbal Medicinal Mixture in Parkinson's disease (PD) patients. The treatment phase includes 12 months period of Herbal Medicinal Mixture per day or placebo and 1 month wash-out period without herbal medicine and placebo.

Detailed Description

This study was designed to evaluate the symptomatic effects or potential disease progression slowing down effect of a kind of Herbal Medicinal Mixture in Parkinson's disease (PD) patients. The treatment phase includes 12 months period of Herbal Medicinal Mixture per day or placebo and 1 month wash-out period without herbal medicine and placebo.

The design of the study was a prospective, randomized, multicenter, double-blind placebo-controlled protocol. The intervention includes Herbal Medicinal Mixture Bid or matched placebo for 12 months plus 1 month wash-out period.

Participating study centers include Neurological University Outpatient Clinics and Neurological Departments of Community-based Hospitals experienced with PD patients.

The primary outcome measure was the combined Unified Parkinson's Disease Rating Scale (UPDRS).

The hypothesis of this study was that Herbal Medicinal Mixture improves the overall wellbeing of PD patients and thus may leads to an improvement of parkinsonian symptoms in PD patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
158
Inclusion Criteria
  • Parkinson's disease according to the UK Brain Bank criteria
  • Hoehn & Yahr stadium Ⅰ~Ⅲ
  • Age over 50 years
  • Taking only levodopa and/or dopamine agonists when recruiting
  • Consistent with the liver kidney deficiency type by Traditional Chinese Medicine (TCM) standard
  • Patients voluntarily take part in this study and signed the informed consent
Exclusion Criteria
  • Modified Hoehn-Yahr scale are higher than 4
  • Had other serious illness such as liver/kidney failure, serious infection etc
  • Allergic to the study drug
  • Had been participated in other clinical trials during the last 3 months prior to study inclusion.
  • Taking Coenzyme Q10, MAO-B inhibitors, or vitamin E, all of which might improve the symptom or slowdown the progression of PD.
  • Taking herbal medicine that can nourish the liver and kidney by TCM standard.
  • Had serious mental disorder and could not describe his/her symptom.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BPlacebo-
AHerbal Medicinal Mixture (Roucongrong, Heshouwu etc.)-
Primary Outcome Measures
NameTimeMethod
Levodopa equivalent dose(LED) per day13 months

daily levodopa dose taken by PD patients to control their symptoms.

Secondary Outcome Measures
NameTimeMethod
Unified Parkinson's Disease Rating Scale (UPDRS)13 months
Hoehn & Yahr scale13 months
Schwab & England score13 months
The liver kidney deficiency scale score by Traditional Chinese Medicine standard13 months
Parkinson disease sleep scale (PDSS)13 months
Assessment of autonomic dysfunction in Parkinson disease (SCOPA-AUT)13 months
Changes in laboratory indexes as safety assessment, including red blood cell(RBC), white blood cell(WBC), platelet(PLT), alanine transaminase (ALT), aspartate transaminase (AST), blood urea nitrogen (BUN), creatinine(Cr) in blood samples, ect.12 months

Trial Locations

Locations (10)

Department of Neurology, Yueyang Hospital of Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

🇨🇳

Shanghai, Shanghai, China

Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

The Sixth People's Hospital, Shanghai Jiaotong University

🇨🇳

Shanghai, Shanghai, China

Department of Neurology, The second people's hospital of Wenzhou

🇨🇳

Wenzhou, Zhejiang, China

Department of Neurology, Xuanwu hospital, Capital University of Medical Sciences

🇨🇳

Beijing, Beijing, China

Shanghai Chinese Medical Hospital

🇨🇳

Shanghai, Shanghai, China

Department of Integrative Medicine, Zhongshan hospital, Fudan University

🇨🇳

Shanghai, Shanghai, China

Department of Nuerology, Xinhua Hospital, Affiliated to Shanghai Jiaotong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

Department of Nuerology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

🇨🇳

Shanghai, Shanghai, China

Tongji Hospital of Tongji University

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath